An Israeli startup that uses artificial intelligence to diagnose cancer has unveiled a new solution that will help pathologists detect the specific treatments that will benefit breast cancer patients most.
Ibex Medical Analytics’ Galen Breast HER2 platform can accurately determine the expression in cancer slides of the protein HER2, which is responsible for the proliferation of breast cancer cells.
The platform uses AI to analyze the slides, identify the tumor cells and rapidly calculate the HER2 score of the tissue. The results are highlighted for the pathologist, who can review them and make a final decision as to what cancer treatment is best for each patient.
Traditionally, pathologists evaluate HER2 in tumor samples visually, which may result in varied interpretations. The Galen Breast HER2 scoring system quantifies the sample’s expression of the protein into four standard categories to help the pathologist make a more accurate decision.
The technology was developed and validated by Ibex in collaboration with AstraZeneca, the British-Swedish multinational biotechnology company, and Daiichi Sankyo, a Japanese pharma company.
“We are committed to providing pathologists with the most comprehensive AI platform as they implement digital pathology,” said Issar Yazbin, VP Product Management at Ibex Medical Analytics.
“In addition to HER2, we are now able to support full review of breast biopsies and excisions, distinguish between multiple types of invasive and non-invasive cancer, detect more than 50 malignant and non-malignant morphological features, and provide the underlying technology for automated quantification of additional prognostic and predictive breast biomarkers such as Ki-67, ER and PR.”
Advanced technology identifies pairs of drugs that can fight disease together, in microscopic doses.
Researchers have developed a pioneering AI “matchmaker” that pairs together existing cancer drugs for use in nanomedicine.
Prescribing a combination of two or more medications is already an established practice – known as combination therapy — that can prove highly effective.
But a team at Technion – Israel Institute of Technology, in Haifa, has gone beyond simply identifying separate medications that will work well together.
These scientists have developed technology that singles out drug pairs whose molecular structure allows them to join together chemically as nanoparticles, measuring just a millionth of a millimeter. Their findings are published in the Journal of Controlled Release.
Administering medicines as nanoparticles – or nanomedicines – has many advantages, allowing doctors to use lower doses, target specific cells and minimize side effects.
The artificial intelligence tool developed at the Technion trawls published articles on existing cancer treatments, gathering information that allows it to predict pairs of drugs that will work well together and, crucially, that are able to chemically assemble into combined nanoparticles.
PhD student Dana Meron Azagury and Prof. Yosi Shamay. Photo courtesy of Technion Spokesperson’s Office
Prof. Yosi Shamay describes the new approach as a “synergy of synergies” or a “meta-synergy.”
The first synergy is the combination of two drugs so that their combined effect is greater than using each of them in isolation.
The second synergy is identifying which of these drugs pairs can be used in nanomedicine, bringing a whole array of new benefits.
The AI tool has so far proposed 1,985 possible nanomedicine drug combinations to treat 70 types of cancer.
One example is combining Bortezomib (a blood cancer drug) and Cabozantinib (a liver, kidney and thyroid cancer drug) as treatment for head and neck cancer. This combination has proven effective and caused fewer side effects than using either of the drugs individually.
Drug synergy prediction produced by the model. Photo courtesy of Technion Spokesperson’s Office
Standard drug combinations combat a tumour more effectively than they would do individually and may prevent the tumour from developing resistance to treatment.
Above and beyond
Master’s student Ben Friedmann. Photo courtesy of Technion Spokesperson’s Office
Nanomedicine combinations go above and beyond. They target cancer cells more precisely, are more successful at fighting tumors, require smaller doses, are less toxic, and minimize side effects.
“The development of meta-synergy on the nanometric level is a very complex challenge,” said Shamay.
“It necessitates the introduction of [at least] two drugs simultaneously into the same delivery system that would lead them to the desired destination in the body,” he said.
“Our research has shown, both in a computational demonstration and in live experiments, that the combination we proposed indeed leads the drugs to the tumor and releases them there — and that this therapy is very effective in treating the disease.”
The study, conducted at the Shamay Lab for Cancer Nanomedicine and Nanoinformatics, was led by PhD student Dana Meron Azagury, whose focus was on the biology and chemistry side of the research, and master’s student Ben Friedmann, who developed the AI model.
Reps from 10 startups spend four days meeting with British executives, investors and policymakers in collaborative events and discussions.
A delegation of climate-tech innovators from Israel enjoyed a morning welcome reception at the British House of Lords, opening a groundbreaking event hosted by Lord Ian Austin from June 26-29.
The UK-Israel Climate First Delegation was organized by Israeli climate-tech accelerator Climate First with the UK-Israel Business Bilateral Chamber of Commerce, which has fostered growth and investment between the UK and Israel since 1950.
Representatives were from Helios (large-scale carbon capture), Hydro X (hydrogen storage and transport), Criaterra (sustainable building materials), Daika (natural materials from wood waste), Gigaton Carbon (ocean-based CO2 removal and storage), Momentick (monitoring greenhouse gas emissions), QD-SOL (green hydrogen), Zohar CleanTech (decentralized waste disposal systems), Luminescent (isothermal heat engine) and NakAI (maritime cleaning and inspection robots).
“Our mission at Climate First is to empower companies that can help us meet our net-zero goals,” said Nadav Steinmetz, cofounder and managing partner of Climate First.
“Through this UK-Israel delegation, we are furthering that mission by bridging the gap between innovative Israeli companies and the UK’s vast network of investors, policymakers and business leaders. Together, we can unlock potential and accelerate the global transition towards a climate-resilient future.”
During their visit, the delegates interacted with British executives, investors and policymakers in collaborative events and discussions. Meetings were scheduled with Lord Browne, founder and chairman of BeyondNetZero; Generation Investment Management Just Climate Fund; Barclays Sustainable Impact Capital; J.P. Morgan ClimateTech; BlackRock Decarbonisation Partners; the European Bank for Reconstruction and Development (EBRD); and representatives from Prince William’s Earthshot Prize.
Prof. Gideon Grader awarded the Institut de France prize for developing the E-TAC process that enables splitting water into hydrogen and oxygen.
Prof. Gideon Grader from Israel’s Technion-Israel Institute of Technology was recently awarded the Grand Prix Scientifique research grant by the Institut de France for developing innovative green hydrogen technology.
The Institut de France, a nonprofit organization founded in 1795 that unites five French academies, encourages research, supports creativity, and funds many humanitarian projects.
Grader has developed a process — dubbed E-TAC — along with his Technion colleagues, which splits water into hydrogen and oxygen by decoupling the production of the two gasses. This is achieved by circulating electrolyte solutions at different temperatures through the electrodes.
The professor later developed unique electrodes that move continuously between the separated sites where the hydrogen and oxygen are produced simultaneously, allowing for the E-TAC process to be continuous and not an isolated action.
The scientists say the method will enable long-term operation at a low cost and easier scaleup to industrial level.
In 2019, green hydrogen company H2Pro was founded using the E-TAC technology. The 100-strong company has since raised over $100 million from venture capital funds, including Bill Gates’ BEV fund, TEMASEK, and Horizon Ventures. H2Pro was recently selected by BloombergNEF as one of the most promising companies for solving the climate change crisis.
News arrives from Israel’s Technion Institute that they have developed a stable catalyst that can split water at extravagantly low energy-levels – and haven’t ruled out being able to split water with energy levels obtainable from the sun.
In fact, the hope of rapid transformation in the field is one of the reasons that AkzoNobel Specialty Chemicals and Gasunie New Energy have partnered in a project aiming at “large scale conversion of sustainable electricity into green hydrogen via the electrolysis of water.”
Intended for Delfzijl in the Netherlands, the installation would use a 20MW water electrolysis unit, the largest in Europe, to convert sustainably produced electricity into 3,000 tons of green hydrogen a year – enough to fuel 300 hydrogen buses. A final decision on the project is expected in 2019.
Why — and why now — is green hydrogen such a big, big deal? Two reasons, really.
One, you’d solve the energy-storage problem of solar power, in a snap — you’d just split water to make hydrogen. (Don’t worry, when you use the hydrogen to, for example, power a car, the water re-forms out of the tailpipe. This isn’t a Water vs Fuel situation.)
Two, you’d have an affordable, biobased (hydrogen fuel) fuel you could make anywhere, in quantities exceeding the petroleum industry.
Scientists have not been able to crack the problem, in part because the catalyst that Nature evolved is complex, and has been described as the “the strongest biological oxidizing agent yet discovered”.
It comes down to controlling manganese, which is abundant and cheap, but the manganese catalysts yet developed never last and consume way too much energy.
Consequently, though Toyota has been working very hard on hydrogen vehicles, hydrogen as currently obtained via natural gas reforming is not green, nor competitively affordable. So, there might be a hundred hydrogen refueling stations in the US, about half of them in California.
In an article published in Nature Catalysis, Assistant Professor Galia Maayan of the Technion-Israel Institute of Technology presents a molecular complex (also called an artificial molecular cluster) that dramatically improves the efficiency of water oxidation. It does so by biomimicry – a field of engineering inspired by nature (bio=life, mimetics=imitation). In this specific case, the inspiration comes from the process of photosynthesis in nature.
The molecular complex developed by Maayan is expected to change this situation. This cluster, which is actually a complex molecule called Mn12DH, has unique characteristics that are advantageous when splitting water.
Experiments conducted with this complex demonstrate that it produces a large quantity of electrons (electric current) and a significant amount of oxygen and hydrogen, despite a relatively low energetic investment. No less important, it is stable – meaning that it is not easily demolished, like other Mn-based catalysts.
An improved plasma thruster using Israeli technology can steer satellites out of harm’s way while using less power than chemical forms of propulsion.
Space is getting crowded.
In addition to the thousands of satellites already orbiting Earth, about 14,000 new satellites are expected to be launched by the end of the decade.
That translates into about 9,000 tons of space debris, says Igal Kronhaus, Technion professor-turned-space-tech startup entrepreneur.
It’s gotten so bad that the United States issued new regulations in 2022 that “won’t allow the launch of a satellite unless it has a convincing capability to move out of the way after five years from the end of the mission,” Kronhaus says.
Kronhaus started his company, Space Plasmatics, in 2021 to address the space junk problem while also improving satellite propulsion in general.
Space Plasmatics is developing plasma thrusters designed to navigate satellites to a different orbit or even back to Earth, using ionized gas in an electric field rather than the traditional propulsion method of chemical reactions.
The thrusters get their power from solar cells that are already mounted on the satellites. Solar-powered electric propulsion is now used in almost every satellite. High-powered versions could even propel manned spacecraft for missions to the Moon and Mars.
Electric propulsion was originally conceived in the 1950s as a way to get people to Mars – long before Elon Musk popularized the concept for the 21st century.
“Back then, there were no envisioned applications, other than human space travel,” Kronhaus tells ISRAEL21c.
Now, with satellites handling everything from GPS navigation to cell phone communication to spying on enemy nations, the use case has arrived.
Space hardware
Kronhaus was an assistant professor of aerospace engineering at the Technion for seven years. The technology for Space Plasmatics, he says, has been “incubating in my lab for the past decade.”
Space Plasmatics cofounder Andrew Pearlman. Photo courtesy of Space Plasmatics
“It’s very unusual for a professor to start a company,” Kronhaus says. “I’m paving a unique path here.”
Space Plasmatics cofounder Andrew Pearlman is a serial entrepreneur who has raised more than $150 million for 10 Israeli companies since his arrival here from the United States in 1981. He describes his role in Space Plasmatics as Kronhaus’s “coach, copilot and righthand man.”
“We’re exclusively space hardware,” Kronhaus says. “We can’t re-use our engines in cars or planes. We’re making a real, physical product, not just writing code. That makes it more difficult to convince investors to come in.”
But some have.
Israel Aerospace Industries (IAI) took an interest in Space Plasmatics and invited the company to participate in the Astra incubator, co-run by the accelerator Starburst and IAI. The Israel Innovation Authority has also helped fund Kronhaus’s vision.
The Knesset last year pledged to invest the shekel equivalent of $180 million in the civilian space industry over the next five years. Start-Up Nation Central estimates the worldwide space economy is worth $400 billion.
Larger satellites
In June, Kronhaus signed a deal to develop its plasma thrusters for IAI’s satellites. This deal points to a shift in the industry.
For much of the past decade, tiny nanosatellites (CubeSats), just a few tens of kilograms in weight, were assumed to be the future of the industry.
Israel excelled at these small satellites.
“It’s no secret that we can’t launch over neighboring Arab states. And we don’t build huge rockets. So, we build smaller rockets with a smaller payload that are launched in the wrong direction!” Kronhaus says.
That “wrong direction” requires more fuel, “so we have to reduce the payload we’re carrying even further.”
But now, the main market seems to be in bigger satellites that weigh several hundred kilograms, Kronhaus says. It makes economic sense – bigger satellites carry bigger payloads, which results in faster ROI.
Larger satellites are also what IAI specializes in.
The IAI arrangement is positioned as a trial to see if Space Plasmatics can scale up to IAI’s needs. Kronhaus is convinced they can and that IAI will become a paying customer.
How it works
For any rocket scientists reading this, here are a few technical details.
Kronhaus’s plasma thrusters are essentially a better version of a Hall thruster, a model developed in the former Soviet Union in the 1960s.
The thruster does need some fuel but uses nonflammable, noncombustible gases such as xenon and krypton.
Space Plasmatics’ microHET thruster prototype. Photo courtesy of Space Plasmatics
“The inert gas is in the propellant tank on the satellite,” Kronhaus says. “The Hall thruster feeds a certain amount of it to the engine at a constant rate. The electric field gives the gas the energy to ionize. There’s a nice blue plasma flame as the ions are accelerated. This acceleration is what produces thrust.”
Kronhaus says that Space Plasmatics’ tech also reduces the weight of the satellite, because normally it’s the fuel tank that contributes the most weight to the device.
Hall thrusters, however, are not for every space application. Landing on the Moon or shooting missiles require the higher power of chemical propulsion.
Space Plasmatics is still developing its thrusters. Assuming the company continues with IAI and/or raises more money, Kronhaus and Pearlman say a full working version of the company’s product should be ready by Q2 2025.
Competition
Space Plasmatics has plenty of competitors: Austria-based Enpulsion; Thrustme and Exotrail from France; Astra and Rafael from Israel.
However, Kronhaus is banking on Space Plasmatics’ high thrust and high fuel economy. “We improve the performance of a Hall engine at low power,” he says.
It doesn’t hurt that Kronhaus has a PhD in electric propulsion and is considered an expert in the field – in Israel and beyond.
Will Kronhaus’s technology and Pearlman’s business savvy be enough for this four-person company in Haifa to make a dent in the space-tech space? We’ll be watching.
Bacteria can be found everywhere, and some are bad and cause illnesses, but some do more good more than harm.
There are thousands of kinds of bacteria – microscopic, single-celled organisms that are among the earliest known life forms on earth and live in every possible environment all over the world. They might be airborne or found in water, plants, soil, animals and even humans, where some cause dangerous diseases such as salmonella, pneumonia, meningitis, tuberculosis, anthrax, tetanus and botulism.
However, many bacteria, including the ones that comprise the human gut microbiome, do good rather than harm. Bacteria can even be turned into tiny factories that manufacture needed products.
Now, researchers at the Faculty of Biotechnology and Food Engineering at the Technion-Israel Institute of Technology in Haifa have developed “bionic bacteria” that have many potential applications in industry.
Among those applications are the targeted release of biological drugs in the body using external light and other precise medical uses, sensing hazardous substances in the environment and the production of better fuels and other compounds.
The study was led by Assistant Prof. Omer Yehezkeli and doctoral student Oren Bachar, and co-authored by doctoral student Matan Meirovich and master’s student Yara Zeibaq. Their work has just appeared in the international edition of Angewandte Chemie under the title “Protein-Mediated Biosynthesis of Semiconductor Nanocrystals for Photocatalytic NADPH Regeneration and Chiral Amine Production.” The journal, which is published by the German Chemical Society, officially described it as a “hot paper.”
“My research group deals with the interface between engineering and biotechnology at the nanoscale level,” said Yehezkeli. “Our goal is to blur the current boundaries between the different disciplines, and mostly between nanometer materials and biological systems such as bacteria. In our research, we use the unique properties of nanoscale particles on the one hand, and the tremendous selectivity of biological systems on the other, to create bionic systems that perform synergistically.”
Nanoscale semiconductor particles are usually produced in chemical processes that demand high temperatures and organic solvents. In the new Technion study, the researchers were able to create – using engineered proteins – an environment that makes possible the growth of nanometer particles under biological conditions and at room temperature. In turn, the grown nanoparticles can lead to light-induced processes of biological components.
“The use of engineered proteins for the self-growth of nanomaterials is a promising strategy that opens up new scientific horizons for combining inanimate and living matter,” added Yehezkeli. In the current study, the researchers demonstrated the use of engineered proteins to grow cadmium sulfide (CdS) nanoparticles that are capable of recycling nicotinamide adenine dinucleotide phosphate (NADPH) with light radiation.
“This is an essential electron donor in all organisms that provides the reducing power to drive numerous reactions, including those responsible for the biosynthesis of all major cell components and many products in biotechnology with light radiation. NADPH is crucial in many enzymatic processes and therefore its generation is desired,” Yehezkeli explained.
CdS nanoparticles have applications as an excellent photographic developer for the detection of cancers and other diseases, and in the treatment of cancer cells. The antibacterial and antifungal biological activity on various foodborne bacteria and fungi can also be studied with the use of CdS nanoparticles.
Enzymes are a common biological component involved in all living cell functions. Billions of years of evolution have led to the development of a broad spectrum of enzymes responsible for the many and varied functions in the cell, said Yehezkeli.
In their study, the researchers showed that NADPH could be produced (recycled) using the genetically modified protein made up of 12 repeating subunits that form a donut-like structure with a three-nanometer “hole” (three-billionths of a meter in diameter).
“This is a preliminary demonstration of the direct connection of inanimate matter [abiotic] with living matter [biotic] and a platform for its operation in a way that does not exist in nature,” concluded Yehezkeli.
“The technology we have developed enables the creation of hybrid components that connect these two types of materials into one unit, and we are already working on fully integrated living cells with promising initial results.
We believe that beyond the specific technological success in the production of NADPH and [various other] materials, there is evidence of the feasibility of a new paradigm that may contribute greatly to improving performance in many areas including energy, medicine, and the environment.”
“There is evidence of the feasibility of a new paradigm that may contribute greatly to improving performance in many areas including energy, medicine, and the environment.”
Israeli food-tech startup More Foods has announced a new partnership with Tivall, a vegetarian frozen food brand owned by food giant Osem-Nestlé.
More Foods makes high-protein, high-fiber meat alternatives from pumpkin and sunflower seeds. Its products are served in over 100 Israeli restaurants as well as restaurants in the UK and France.
The startup says its high-protein product uses the seeds in a way that allows for textures and flavors that are not usually found in meat substitutes, mimicking the variety available for meat eaters.
The collaboration with Tivall, which is based on Kibbutz Lohamei HaGeta’ot in northern Israel, will allow More Foods to expand its distribution to meet the growing demand for clean, plant-based products.
This partnership marks Tivall’s first time working with a food-tech startup.
“We are proud to partner with the Osem-Nestlé Group and combine our unique product offering with their market accessibility,” said Leonardo Marcovitz, founder of More Foods.
“This collaboration represents an important milestone in our journey to broaden our market presence, reach a larger customer base, and further our mission to make nutritious meaty center-plate plant-based products more accessible to consumers worldwide,” he said.
More Foods was founded in 2019 and is headquartered in Tel Aviv.
The daily commute for many Israelis means long hours by bus or car, navigating a gridlocked central Israel – the heart of the country’s business sector.
Israel’s traffic jams are notorious. In 2021, the Organization for Economic Cooperation and Development (OECD) said that the country’s transportation infrastructure was in worse shape than most of its other members – and singled out the congestion on the roads as being especially egregious.
But Israel – with its strong tech ecosystem and ethos of innovation – has devised a futuristic solution to dodge traffic jams by sending people and parcels to their destination through the air in unmanned aerial vehicles (also known as UAVs or drones).
Dronery’s UAV is designed to carry people through the air for distances of up to 30km (Mark Nomdar)
And this month, that solution moved even closer to reality, with the Israel National Drone Initiative (INDI) testing drones that can carry both passengers and goods.
INDI has been in development for the past four years, bringing together a variety of government bodies, including the Ministry of Transport, the Israel Innovation Authority (IIA) and the Civil Aviation Authority of Israel (CAAI).
The IIA says the drone initiative is preparing the groundwork for the regular use of these unmanned flying vehicles in Israel, building the technology, regulation and infrastructure ahead of their introduction.
The aim, it says, is not only to alleviate the human and environmental pressure on Israel’s roads, but also offer more efficient services and give the country’s high-tech sector a competitive edge on the global stage.
Israel has invested 60 million shekels (approx. $16.5 million) in the project so far.
This month’s tests involved 11 companies working in drone operation, including two whose aircraft are intended to transport people.
The companies carried out trial missions at multiple locations across the country. And Daniella Partem, who heads Israel’s drone project as part of her leadership role at the IIA, says her team was pleasantly surprised at how swiftly they were making progress.
The tests included groundbreaking autonomous flights by a pair of Israeli companies whose eVTOL (Electric Vertical Takeoff and Landing) craft can carry two people at a time.
“We thought it would take longer to fly the eVTOLs in Israel,” Partem tells NoCamels, explaining that no other country is working in such an accelerated way in this field.
“Our main objective is to have this competitive, safe ecosystem operating in Israel, and as opposed to other countries, we’re very focused and have a managing aerial system.”
The two companies planning to carry passengers are Dronery, whose Chinese-made, Israeli-adapted craft can carry 220 kg in cargo and fly as far as 30 km, and AIR, whose homegrown AIR ONE craft can carry up to 250 kg and for a far greater distance of 160 km.
Their test flights involved taking off and landing in urban areas and the transportation of heavy cargo. Both sets of tests were conducted successfully using mannikins.
Dronery tests its UAV designed to carry people from one location to another (Courtesy)
The government says that the test flights will continue around the country for the next two years, with the aircraft flying long distances of up to 150 km while increasing the weight of their payload in order to prepare for passengers.
For Partem, this is just the beginning of a transportation revolution that could even see drones helping in life or death situations, such as delivering rare medications or ferrying patients between hospitals in emergencies. And the program is advancing satisfactorily.
“We’ve managed to move forward pretty quickly into creating this new ecosystem for drones and eVTOLs. And this is a very important milestone for us and the project; we’ve done over 19,000 sorties, in different places in Israel – up north, down south, Tel Aviv, Jerusalem,” she tells NoCamels.
“We believe that this whole technology is something that can really help solve urgent problems such as traffic and such as air pollution, and help us move things from place to place in a more efficient and safe way,” Partem says.
Safe Skies
With an active air force due to Israel’s security situation, the use of drones in the country’s heavily defended airspace inevitably involves some close coordination with the military.
The technology to manage the airspace and the “corridors” (think roads in the sky) that the aircraft will be using is currently being developed, Partem says.
Israel has tasked two companies with managing the airspace and, according to Partem, both will be employing the Unmanned Aircraft System Traffic Management (UTM) devised by the United States.
Unlike in other countries, in Israel the airspace management will be overseen by the government, but the actual operation of the drones will be open to many companies, creating what Partem calls a “competitive ecosystem.”
Each company will have to register with the authorities and limit themselves to a predetermined route but will ultimately be responsible for their own craft and their contents. The UTM, Partem says, “only helps them fly together in one space.”
Partem is confident in the software and the hardware that comprises the safety measures in place for all bodies and interested parties, and cites an example of these security steps in action.
“We had a helicopter flying into the airspace where the drones are flying. And you could see how the drones made their way around the helicopter. We can really see that we can have a safe environment,” she says.
A startup that generates detailed 3D maps of underground utilities without the need for excavation is expanding into the UK as part of a project with one of the country’s largest railway infrastructure companies.
Tel Aviv-based Exodigo helps companies carry out construction projects by combining 3D imaging and AI technologies with GPR (ground penetrating radar) and electromagnetic sensors to give a clear picture of what’s underground.
Coles Rail used Exodigo’s technology to scan and map a project in Birmingham for part of a light rail expansion that will connect to the city’s Curzon Street Station.
The UK-based company encountered “uncharted services” that were not noted on any existing records. Using Exodigo, Coles Rail was able to detect over 280 below ground utility lines (including 51 additional lines that no other locator or records had detected), providing invaluable data that reduced redesigns and delays.
Exodigo’s tech can identify water and gas pipes, electricity cables, water sources, and other buried obstacles that could cause leaks, explosions or unexpected delays. Actual excavations are time consuming, inaccurate, expensive, and can cause leaks, explosions, or unexpected delays.
“Redesigns and service strikes as a result of incomplete or inaccurate subsurface mapping continue to be a problem in the UK,” said Trevor Moore, UK Director of Exodigo.
“In my time in the industry, I have seen these issues cause costly delays to critical projects and it puts lives at risk. Exodigo’s technology has the potential to mitigate many of the risks associated with large infrastructure projects by providing comprehensive information about what lies beneath the surface.”
Hamish Falconer, Project Manager on the rail extension for Coles Rail, said: “Excavating around buried services is one of our biggest risks, and the stat plans provided by statutory undertakers are in large part inaccurate.
“Exodigo’s surveys provide us with much more reliable data that can then be used to select safer excavation techniques around known services.”
